Mia D. Champion, PhD
Affiliations: | Mayo Clinic, Rochester, MN, United States |
Area:
Bioinformatics ScientistWebsite:
http://www.researchgate.net/profile/Mia_ChampionGoogle:
"Mia Champion"Bio:
PhD thesis with R.Scott Hawley
Parents
Sign in to add mentorR Scott Hawley | grad student | 2002 | UC Davis | |
(Identification of genes that are dosage -sensitive modifiers of nod phenotype and act to properly segregate achiasmate chromosomes.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Borad MJ, Egan JB, Condjella RM, et al. (2016) Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25 |
Ho TH, Nateras RN, Yan H, et al. (2015) A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. Plos One. 10: e0132831 |
Ho TH, Park IY, Zhao H, et al. (2015) High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene |
Zhu YX, Yin H, Bruins LA, et al. (2015) RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125: 483-91 |
Kortüm KM, Langer C, Monge J, et al. (2015) Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. British Journal of Haematology. 168: 507-10 |
Francis P, Alvarez LM, Lenkiewicz E, et al. (2015) Abstract P2-03-07: Deep clonal profiling identifies distinct mechanisms of heterogeneity and evolution in breast cancer Cancer Research. 75 |
Champion MD, Francis P, Pockaj BA, et al. (2015) Abstract 4861: Hybrid clustering methodologies to distinguish CNAs and/or SNVs that drive subclonal differentiation in samples from a breast cancer patient primary tumor and metastatic lymph nodes Cancer Research. 75: 4861-4861 |
Borad MJ, Champion MD, Egan JB, et al. (2014) Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135 |
Egan JB, Barrett MT, Champion MD, et al. (2014) Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. Plos One. 9: e87113 |
Bryce AH, Borad MJ, Condjella RM, et al. (2014) A study of real-time CLIA-enabled whole genome tumor sequencing: Results for testicular cancer and sarcomatoid RCC. Journal of Clinical Oncology. 32: 463-463 |